CClinicalTrials.gg
CompletedNCT03089593Updated Jun 21, 2017

Thermogenic Effect of Ginger

An interventional study of Extract of ginger and Placebo (Cellulose) in Healthy Volunteers, sponsored by Federal University of Minas Gerais. Completed at 1 site in Brazil. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-06-21.

Sponsored by Federal University of Minas Gerais · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

The main objective of the study is to evaluate the thermogenic effect of ginger.

Read the detailed description

Healthy and eutrophic women will receive capsules of 200 mg of ginger extract (5% active ingredient) or placebo (cellulose), along with a standardized breakfast, with a minimum seven days washout period.

02

Conditions studied

  • Healthy Volunteers

Keywords

  • Thermic Effect of Food
  • Energy Expenditure
  • Ginger
03

In context

Lead sponsor

Federal University of Minas Gerais is the lead sponsor of 150 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Females;
  • Aged between 18 and 60 years old;
  • Body mass index between 18.5 and 24.9 kg/m²;
  • Agree to sign the informed consent.

Exclusion criteria

Exclusion Criteria:

  • Any chronic health conditions (e.g. diabetes, hypertension, chronic renal failure, heart and liver disease);
  • Previous operation for weight loss;
  • Medications known to affect total energy expenditure;
  • Pregnancy and breast-feeding;
  • Smoking;
  • Alcohol use (>2 doses/day).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Extract of ginger

    Healthy and eutrophic women will receive two capsules of 200 mg of ginger extract (5% gingerols) to be taken along with a standardized breakfast.

    Other: Extract of ginger

  • Placebo comparator
    Cellulose

    Healthy and eutrophic women will receive two capsules of 200 mg of placebo (cellulose) to be taken along with a standardized breakfast.

    Other: Placebo (Cellulose)

Interventions

  • OtherExtract of ginger

    The volunteers will receive two capsules containing 200mg of extract of ginger with 5% of gingerols (20 mg). Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.

  • OtherPlacebo (Cellulose)

    The volunteers will receive two capsules containing cellulose (placebo). Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.

06

What researchers measure

Primary outcomes

  1. Change in postprandial energy expenditure

    Energy expenditure will be assessed by indirect calorimetry

    Time frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

Secondary outcomes

  1. Change in oxygen consumption

    Oxygen consumption will be assessed by indirect calorimetry

    Time frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  2. Change in blood pressure

    Blood pressure will be assessed using digital sphygmomanometer

    Time frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  3. Change in axillary temperature

    Axillary temperature will be assessed using a digital thermometer

    Time frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  4. Change in metabolic profile

    Total cholesterol

    Time frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial

  5. Change in heart rate

    Heart rate will be assessed using digital sphygmomanometer

    Time frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  6. Change in metabolic profile

    Glucose levels

    Time frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial

  7. Change in metabolic profile

    HDL-cholesterol

    Time frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial

07

Study locations

1 site
  • Hospital das Clínicas
    Belo Horizonte, Minas Gerais 30130-100, Brazil
08

References and documents

Publications

  • Fagundes GBP, Rodrigues AMDS, Martins LB, Monteze NM, Correia MITD, Teixeira AL, Ferreira AVM. Acute effects of dry extract of ginger on energy expenditure in eutrophic women: A randomized clinical trial. Clin Nutr ESPEN. 2021 Feb;41:168-174. doi: 10.1016/j.clnesp.2020.10.001. Epub 2020 Nov 9. PubMed 33487261 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03089593
Lead sponsor
Federal University of Minas Gerais
Responsible party
Adaliene Versiani M. Ferreira (Principal Investigator, PhD, Federal University of Minas Gerais) — Principal investigator
First posted
Mar 24, 2017
Start date
Mar 27, 2017
Primary completion
Jun 14, 2017
Completion
Jun 14, 2017
Last update
Jun 21, 2017

Study contacts

Gabriela BP Fagundes
study chair · Federal University of Minas Gerais

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion